CL7 Funds Over $300K in Second Round of Research Grants

On this opening day of Major League Baseball, we are thrilled to share that The Charlie Landers Foundation (CL7) has committed to funding our second round of research grants. We are tremendously fortunate to allocate over $300,000 to 3 high impact grants in the ongoing search for a cure. Thank you to our stellar Medical Advisory Board for your guidance, commitment and leadership in making these important determinations.

Congratulations to the following researchers and their teams. We are indebted to them for their critical work and focus to strike out Ewing’s Sarcoma.

PI: Kelly M Bailey MD, PhD

Institution: UPMC Children’s Foundation

Study Title: The role of galectin-3 in metastatic Ewing sarcoma

Total Grant: $62,034 (second year funding)

PI: Dr. E. Alejandro Sweet-Cordero

Institution: The Regents of the University of California, San Francisco

Study Title: Mechanisms of recurrence after chemotherapy in Ewing Sarcoma

Total Grant: $150,000

PI: Mats Ljungman, PhD

Institution: University of Michigan, Ann Arbor

Study Title: Targeting Fusion Oncogenes in Ewing Sarcoma Using CRISPR

Total Grant: $125,849